Anterogencoltd Stock Beta
| 065660 Stock | KRW 19,380 230.00 1.20% |
AnterogenCoLtd fundamentals help investors to digest information that contributes to AnterogenCoLtd's financial success or failures. It also enables traders to predict the movement of AnterogenCoLtd Stock. The fundamental analysis module provides a way to measure AnterogenCoLtd's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to AnterogenCoLtd stock.
AnterogenCoLtd |
AnterogenCoLtd Company Beta Analysis
AnterogenCoLtd's Beta is one of the most important measures of equity market volatility. Beta can be thought of as asset elasticity or sensitivity to market. In other words, it is a number that shows the relationship of an equity instrument to the financial market in which this instrument is traded. For example, if Beta of equity is 2, it is expected to significantly outperform market when the market is going up and significantly underperform when the market is going down. Similarly, Beta of 1 indicates that an asset and market will generate similar returns over time.
Current AnterogenCoLtd Beta | 0.37 |
Most of AnterogenCoLtd's fundamental indicators, such as Beta, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, AnterogenCoLtd is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In a nutshell, Beta is a measure of individual stock risk relative to the overall volatility of the stock market. and is calculated based on very sound finance theory - Capital Assets Pricing Model (CAPM).However, since Beta is calculated based on historical price movements it may not predict how a firm's stock is going to perform in the future.
| Competition |
In accordance with the recently published financial statements, AnterogenCoLtd has a Beta of 0.3671. This is 57.31% lower than that of the Healthcare sector and significantly higher than that of the Pharmaceuticals industry. The beta for all Republic of Korea stocks is notably lower than that of the firm.
Did you try this?
Run Instant Ratings Now
Instant RatingsDetermine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance |
| All Next | Launch Module |
As returns on the market increase, AnterogenCoLtd's returns are expected to increase less than the market. However, during the bear market, the loss of holding AnterogenCoLtd is expected to be smaller as well.
AnterogenCoLtd Fundamentals
| Return On Equity | -5.92 | |||
| Return On Asset | -0.0231 | |||
| Profit Margin | (1.32) % | |||
| Operating Margin | (0.77) % | |||
| Current Valuation | 836.51 B | |||
| Shares Outstanding | 7.95 M | |||
| Shares Owned By Insiders | 21.02 % | |||
| Shares Owned By Institutions | 5.63 % | |||
| Price To Sales | 103.53 X | |||
| Revenue | 8.12 B | |||
| Gross Profit | 1.72 B | |||
| EBITDA | (2.96 B) | |||
| Net Income | (553.98 M) | |||
| Cash And Equivalents | 6.97 B | |||
| Debt To Equity | 43.70 % | |||
| Current Ratio | 3.83 X | |||
| Cash Flow From Operations | (3.05 B) | |||
| Beta | 0.37 | |||
| Market Capitalization | 108.41 B | |||
| Total Asset | 136.7 B | |||
| Net Asset | 136.7 B |
About AnterogenCoLtd Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze AnterogenCoLtd's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of AnterogenCoLtd using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of AnterogenCoLtd based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Other Information on Investing in AnterogenCoLtd Stock
AnterogenCoLtd financial ratios help investors to determine whether AnterogenCoLtd Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in AnterogenCoLtd with respect to the benefits of owning AnterogenCoLtd security.